Vijay R Nadipelli,

Vijay Nadipelli, BPharm, MS, is the Head of Global Health Economics & Outcomes Research at Indivior Inc., North Chesterfield, Virginia, USA, a global specialty pharmaceutical company with a mission to discover and develop innovative medications that help transform the lives of patients with addiction and co-occurring disorders. In his current role, Mr. Nadipelli leads health outcomes research and scientific communications to inform and guide access to addiction treatments with a focus on quality and cost of care, with the ultimate goal of improving population health.
Mr. Nadipelli has two decades of experience conducting prospective and retrospective studies in multiple disease conditions. His most recent focus has been studying people affected by opioid use disorder to understand the multi- dimensional aspects of their recovery, including substance use, health, lifestyle, and community involvement. He led the conceptualization, development, and implementation of the prospective 24-month RECOVERTM Study (Remission from Chronic Opioid Use—Studying Environmental and Socio- economic Factors on Recovery), one of the few studies exploring long-term recovery outcomes. Mr. Nadipelli’s pioneering work in addiction medicine also includes the study of factors associated with opioid overdose and how medication adherence relates to relapse, healthcare resource utilization, and costs from a health systems perspective. The outcomes of these studies have been presented at national and international scientific congresses and published in top-tier scientific journals.
Mr. Nadipelli received his BPharm degree from Kakatiya University, Telangana, India and his Masters in Pharmaceutical Sciences from the University of Georgia, Athens, Georgia, USA. He completed a Fellowship in Pharmacoeconomics and Outcomes Research at Thomas Jefferson University & University of Sciences, Philadelphia, Pennsylvania, USA and is currently pursuing a Masters in Health Policy with a focus on population health at Thomas Jefferson University.